Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture
- PMID: 9048612
- DOI: 10.1210/endo.138.3.4966
Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture
Abstract
The cytokines are the putative mediators of the catabolic reaction that accompanies infection and trauma. Evidence suggests that their catabolic actions are indirect and potentially mediated through changes in hormonal axis such as the hypothalamo-pituitary-adrenal axis. Insulin-like growth factor I (IGF-I) is a GH-dependent growth factor that regulates the protein metabolism. To determine whether cytokines can directly inhibit the production of IGF-I by the liver, we investigated the regulation of IGF-I gene expression by interleukin (IL)-1 beta, IL-6, and tumor necrosis factor (TNF)-alpha (10 ng/ml) in a model of rat primary cultured hepatocytes. Hepatocytes were isolated by liver collagenase perfusion and cultured on Matrigel 48 h before experiments. Each experiment was performed in at least three different animals. In the absence of GH, IL-1 beta and TNF-alpha did not affect the IGF-I messenger RNA (mRNA) basal levels, whereas IL-6 increased it by a factor of 2.5 after 24 h (P < 0.05). GH (500 ng/ml) alone stimulated the IGF-I gene expression markedly (5-to 10-fold increase) after 24 h (P < 0.001). IL-1 beta, and TNF-alpha to a lesser extent, dramatically inhibited the IGF-I mRNA response to GH (IL-1 beta: -82%, P < 0.001 and TNF-alpha: -47%, P < 0.01). The half-maximal inhibition of the IGF-I mRNA response to GH was observed for a concentration of IL-1 beta between 0.1 and 1 ng/ml. Moreover, IL-1 beta abolished the IL-6-induced IGF-I mRNA response. In contrast, IL-6 did not impair the IGF-I mRNA response to GH. To determine the potential role of the GH receptor (GHR) and the GH-binding protein (GHBP) in this GH resistance, we assessed the GHR and GHBP mRNAs response to these cytokines. GH alone did not affect the GHR/GHBP mRNA levels. IL-1 beta markedly decreased the GHR and GHBP mRNA levels (respectively, -68% and -60%, P < 0.05). Neither TNF-alpha nor IL-6 affected the GHR/GHBP gene expression. In conclusion, our results show that IL-1 beta, and TNF-alpha to a lesser extent, blunt the IGF-I mRNA response to GH. The resistance to GH induced by IL-1 beta might be mediated by a decrease of GH receptors, as suggested by the marked reduction of GHR mRNA. These findings suggest that decreased circulating IGF-I, in response to infection and trauma, may be caused by a direct effect of cytokines at the hepatocyte level.
Similar articles
-
Proinflammatory cytokines interleukin 1 beta and tumor necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells.Eur J Endocrinol. 1996 Dec;135(6):729-37. doi: 10.1530/eje.0.1350729. Eur J Endocrinol. 1996. PMID: 9025720
-
Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.Endocrinology. 1992 Jun;130(6):3257-64. doi: 10.1210/endo.130.6.1375898. Endocrinology. 1992. PMID: 1375898
-
Dexamethasone inhibits both growth hormone (GH)-induction of insulin-like growth factor-I (IGF-I) mRNA and GH receptor (GHR) mRNA levels in rat primary cultured hepatocytes.Growth Horm IGF Res. 1999 Jun;9(3):205-11. doi: 10.1054/ghir.1999.0110. Growth Horm IGF Res. 1999. PMID: 10502457
-
Structure and regulation of expression of the mouse GH receptor.J Endocrinol. 2002 Oct;175(1):55-9. doi: 10.1677/joe.0.1750055. J Endocrinol. 2002. PMID: 12379490 Review.
-
Clinical review 112: Does serum growth hormone (GH) binding protein reflect human GH receptor function?J Clin Endocrinol Metab. 2000 Mar;85(3):927-32. doi: 10.1210/jcem.85.3.6461. J Clin Endocrinol Metab. 2000. PMID: 10720017 Review.
Cited by
-
Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia.J Cachexia Sarcopenia Muscle. 2011 Dec;2(4):191-200. doi: 10.1007/s13539-011-0043-5. Epub 2011 Oct 20. J Cachexia Sarcopenia Muscle. 2011. PMID: 22207907 Free PMC article.
-
Neuroendocrine-immune aspects of accelerated aging in rheumatoid arthritis.Curr Rheumatol Rep. 2005 Oct;7(5):389-94. doi: 10.1007/s11926-005-0027-6. Curr Rheumatol Rep. 2005. PMID: 16174490 Review.
-
Expression of growth hormone receptor and its mRNA in hepatic cirrhosis.World J Gastroenterol. 2003 Apr;9(4):765-70. doi: 10.3748/wjg.v9.i4.765. World J Gastroenterol. 2003. PMID: 12679928 Free PMC article.
-
Insulinlike growth factor I plus insulinlike growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burned children.Ann Surg. 2000 Feb;231(2):246-52. doi: 10.1097/00000658-200002000-00014. Ann Surg. 2000. PMID: 10674617 Free PMC article.
-
TNF-alpha downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding.J Clin Invest. 2001 Jun;107(11):1451-8. doi: 10.1172/JCI10994. J Clin Invest. 2001. PMID: 11390427 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources